|
US3865939A
(en)
|
1973-02-23 |
1975-02-11 |
Procter & Gamble |
Edible oils having hypocholesterolemic properties
|
|
SE8600632D0
(sv)
|
1986-02-13 |
1986-02-13 |
Kabivitrum Ab |
Novel pharmaceutical composition
|
|
US5319115A
(en)
|
1987-08-25 |
1994-06-07 |
Cocensys Inc. |
Method for making 3α-hydroxy, 3β-substituted-pregnanes
|
|
US5232917A
(en)
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
|
US5120723A
(en)
|
1987-08-25 |
1992-06-09 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
|
US5719197A
(en)
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
US5497763A
(en)
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
|
JP4008024B2
(ja)
|
1993-05-24 |
2007-11-14 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
Ｇａｂａａレセプター複合体と相互作用させるための化合物
|
|
KR100338287B1
(ko)
|
1994-02-14 |
2002-11-30 |
푸르듀 파머 리미티드 |
감마-아미노부티르산a수용체의알로오스테리조절용안드로스탄및프레그난
|
|
GEP20002033B
(en)
|
1994-11-23 |
2000-04-10 |
Cocensys Inc Us |
Androstane and Pregnane Series Compounds for Allosteric Modulation of GABA Receptor
|
|
US6780853B1
(en)
|
1995-06-06 |
2004-08-24 |
Euro-Celtique S.A. |
Neuroactive steroids of the androstane and pregnane series
|
|
ES2235187T3
(es)
|
1995-06-06 |
2005-07-01 |
Euro-Celtique S.A. |
Esteroides neuroactivos de las series del androstano y el pregnano.
|
|
JP4313435B2
(ja)
|
1995-07-24 |
2009-08-12 |
トラスティーズ オブ ボストン ユニバーシティー |
プレグネノロンサルフェート誘導体によるｎｍｄａレセプター活性の抑制
|
|
US7630757B2
(en)
|
1997-01-06 |
2009-12-08 |
Flint Hills Scientific Llc |
System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
|
|
US6245757B1
(en)
|
1997-10-03 |
2001-06-12 |
Research Corporation Technologies, Inc. |
Use of progestins to treat ischemic event
|
|
WO1999045931A1
(en)
*
|
1998-03-11 |
1999-09-16 |
Baeckstroem Torbjoern |
Epiallopregnanolone in the treatment of cns disorders
|
|
EP1175390B1
(en)
|
1999-04-05 |
2005-02-02 |
Emisphere Technologies, Inc. |
Disodium salts, monohydrates, and ethanol solvates
|
|
US20030236236A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
US20020072509A1
(en)
|
2000-10-11 |
2002-06-13 |
Stein Donald Gerald |
Methods for the treatment of a traumatic central nervous system injury
|
|
GR1003861B
(el)
|
2000-12-29 |
2002-04-11 |
|
Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
EP1392260A2
(en)
|
2001-05-24 |
2004-03-03 |
Alexza Molecular Delivery Corporation |
Delivery of benzodiazepines through an inhalation route
|
|
AU2002310085B2
(en)
|
2001-05-24 |
2008-09-04 |
Alexza Pharmaceuticals, Inc. |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
|
JP2003063965A
(ja)
|
2001-06-13 |
2003-03-05 |
Otsuka Pharmaceut Factory Inc |
注射用シロスタゾール水性製剤
|
|
US8354438B2
(en)
|
2001-08-08 |
2013-01-15 |
Michael Chez |
Neurological functions
|
|
US20040138187A1
(en)
|
2002-08-28 |
2004-07-15 |
Reading Christopher L. |
Therapeutic treatment methods
|
|
EP1626980A4
(en)
|
2003-05-29 |
2007-07-04 |
Univ Washington |
NEUROACTIVE 13,24-CYCLO-18,21-DINORCHOLANES AND STRUCTURELY RELATED PENTACYCLIC STEROIDS
|
|
WO2005011612A2
(en)
|
2003-07-31 |
2005-02-10 |
The Research Foundation Of State University Of New York |
Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
|
US20060063707A1
(en)
|
2004-09-17 |
2006-03-23 |
Lifelike Biomatic, Inc. |
Compositions for enhancing memory and methods therefor
|
|
WO2006037016A2
(en)
*
|
2004-09-27 |
2006-04-06 |
The Regents Of The University Of California |
Novel therapy for treatment of chronic degenerative brain diseases and nervous system injury
|
|
CA2597716A1
(en)
|
2005-02-15 |
2006-08-24 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
|
DK1868614T3
(da)
|
2005-03-24 |
2012-11-12 |
Univ Emory |
Dosisregime til behandling af en traumatisk hjerneskade med progesteron
|
|
CA2604887A1
(en)
|
2005-04-07 |
2006-10-19 |
Hythiam, Inc. |
Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
|
|
US20110319386A1
(en)
|
2005-08-26 |
2011-12-29 |
Braincells Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
KR101415329B1
(ko)
*
|
2005-11-28 |
2014-07-04 |
마리누스 파마슈티컬스 |
ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
|
|
US20070287931A1
(en)
|
2006-02-14 |
2007-12-13 |
Dilorenzo Daniel J |
Methods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
|
|
US20080026918A1
(en)
*
|
2006-07-27 |
2008-01-31 |
Michael Lemke |
Athletic training device with multi-directional movement
|
|
US20090239942A1
(en)
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
|
US20090203658A1
(en)
|
2007-01-08 |
2009-08-13 |
Duke University |
Neuroactive steroid compositions and methods of use therefor
|
|
US20090074677A1
(en)
|
2007-01-08 |
2009-03-19 |
Duke University |
Neuroactive steroid compositions and methods of use therefor
|
|
US7813811B2
(en)
|
2007-02-08 |
2010-10-12 |
Neuropace, Inc. |
Refillable reservoir lead systems
|
|
US20080243022A1
(en)
|
2007-03-30 |
2008-10-02 |
Donnett James G |
Seizure prediction using brain signal telemetry
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
JP2010530371A
(ja)
|
2007-06-11 |
2010-09-09 |
ユニバーシティ オブ サザン カリフォルニア |
神経学的機能を増強するための作用物質、組成物および方法
|
|
AU2008265898B2
(en)
|
2007-06-15 |
2013-11-28 |
Research Triangle Institute |
Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties
|
|
GB0711948D0
(en)
|
2007-06-20 |
2007-08-01 |
Bionature E A Ltd |
Neurosteriod compounds
|
|
US20100316678A1
(en)
|
2007-06-28 |
2010-12-16 |
Cnsbio Pty Ltd. |
Combination methods and compositions for treatment of neuropathic pain
|
|
US9788744B2
(en)
|
2007-07-27 |
2017-10-17 |
Cyberonics, Inc. |
Systems for monitoring brain activity and patient advisory device
|
|
US20100297181A1
(en)
|
2007-12-26 |
2010-11-25 |
Eisai R&D Management Co., Ltd. |
AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
US8729070B2
(en)
|
2008-02-20 |
2014-05-20 |
Targia Pharmaceuticals |
CNS pharmaceutical compositions and methods of use
|
|
CN106243100B
(zh)
|
2008-10-10 |
2019-04-09 |
Vm生物医药公司 |
治疗酒精使用障碍，疼痛和其他疾病的药物组合与方法
|
|
EP2376073A2
(en)
|
2008-11-30 |
2011-10-19 |
Oron Zachar |
Dermal application of vasoconstrictors
|
|
US20100168603A1
(en)
|
2008-12-23 |
2010-07-01 |
Himes David M |
Brain state analysis based on select seizure onset characteristics and clinical manifestations
|
|
US20110306579A1
(en)
|
2009-01-30 |
2011-12-15 |
Emory University |
Methods of neuroprotection using neuroprotective steroids and a vitamin d
|
|
CA2753641C
(en)
*
|
2009-02-25 |
2014-09-16 |
Supratek Pharma, Inc. |
Bendamustine cyclopolysaccharide compositions
|
|
US20120142645A1
(en)
|
2009-03-17 |
2012-06-07 |
Marx Christine E |
Neuroactive steroid compositions and methods of use for lowering cholesterol
|
|
US20110152840A1
(en)
|
2009-12-23 |
2011-06-23 |
Drugtech Corporation |
Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
|
|
PT2525798T
(pt)
|
2010-01-21 |
2017-11-15 |
Drawbridge Pharmaceuticals Pty Ltd |
Formulação anestésica
|
|
CN103313744B
(zh)
|
2010-11-03 |
2015-06-10 |
赛诺菲-安万特德国有限公司 |
容纳药物的针插管
|
|
WO2012075286A2
(en)
|
2010-12-01 |
2012-06-07 |
The Regents Of The University Of California |
Intrapulmonary benzodiazepine for the treatment and prevention of seizures
|
|
US9084797B2
(en)
|
2011-05-23 |
2015-07-21 |
Besins Healthcare Luxembourg Sarl |
Progesterone treatment for improving sleep quality
|
|
KR20130002292A
(ko)
|
2011-06-28 |
2013-01-07 |
주식회사 비보존 |
다중 타겟팅의 상승 효과를 유발하는 유효물질의 조합 및 그 용도
|
|
CA2843436A1
(en)
|
2011-07-29 |
2013-02-07 |
The Regents Of The University Of California |
Novel 17.beta.-heteroaryl-substituted steroids as modulators of gaba a receptors
|
|
EP4245369A3
(en)
|
2011-09-08 |
2023-11-22 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
US10478505B2
(en)
|
2011-09-23 |
2019-11-19 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
|
AU2012323888A1
(en)
|
2011-10-14 |
2014-05-29 |
Sage Therapeutics, Inc. |
3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
|
|
RU2014121785A
(ru)
|
2011-11-29 |
2016-01-27 |
Амино Ап Кемикал Ко., Лтд. |
Композиция, содержащая виценин-2, обладающая благоприятным воздействием на неврологическую или когнитивную функцию
|
|
AU2013212287B2
(en)
*
|
2012-01-23 |
2017-11-23 |
Sage Therapeutics, Inc. |
Neuroactive steroid formulations and methods of treating CNS disorders
|
|
US20150175651A1
(en)
|
2012-06-15 |
2015-06-25 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
WO2014028398A2
(en)
|
2012-08-13 |
2014-02-20 |
The Regents Of The University Of California |
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
|
|
IL304912A
(en)
|
2012-08-21 |
2023-10-01 |
Sage Therapeutics Inc |
Treatment methods for epilepsy and status epilepticus
|
|
EP2916846B1
(en)
|
2012-11-09 |
2025-09-17 |
Drawbridge Pharmaceuticals Pty Ltd |
Neuroactive steroids and their use to facilitate neuroprotection
|
|
EP4335505A3
(en)
|
2012-11-30 |
2024-06-05 |
The Regents of The University of California |
Anticonvulsant activity of steroids
|
|
WO2014108808A2
(en)
|
2013-01-09 |
2014-07-17 |
Henry James Lorne |
Pharmaceutical formulations for the treatment and prevention of trauma-induced neuropathology and neurodegeneration
|
|
US10246482B2
(en)
|
2014-06-18 |
2019-04-02 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
EP3362069A4
(en)
|
2015-10-14 |
2019-10-02 |
The Regents of The University of California |
INCREASING BETA CELL REPLICATION AND / OR SURVIVAL
|
|
HK1258616A1
(zh)
|
2016-03-08 |
2019-11-15 |
Sage Therapeutics, Inc. |
神经活性类固醇、组合物、及其用途
|
|
US20180050107A1
(en)
|
2016-08-16 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Neurosteroid compositions and methods of use thereof
|
|
US20180050005A1
(en)
|
2016-08-16 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Concentrated Solution of 17-Hydroxydocosahexaenoic Acid
|
|
US10098895B2
(en)
|
2016-09-07 |
2018-10-16 |
Glia, Llc |
Treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nerves
|
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|